Related references
Note: Only part of the references are listed.Targeted Theranostic Platinum(IV) Prodrug with a Built-In Aggregation-Induced Emission Light-Up Apoptosis Sensor for Noninvasive Early Evaluation of Its Therapeutic Responses in Situ
Youyong Yuan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Robust Structure and Reactivity of Aqueous Arsenous Acid-Platinum(II) Anticancer Complexes
Denana U. Miodragovic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Gd-DTPA-loaded polymer-metal complex micelles with high relaxivity for MR cancer imaging
Peng Mi et al.
BIOMATERIALS (2013)
A platinum anticancer theranostic agent with magnetic targeting potential derived from maghemite nanoparticles
Jinzhuan Wang et al.
CHEMICAL SCIENCE (2013)
Synthesis and Physicochemical Characterisation of Gd-DTPA Derivatives as Contrast Agents for MRI
Sophie Laurent et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2012)
Using a Build-and-Click Approach for Producing Structural and Functional Diversity in DNA-Targeted Hybrid Anticancer Agents
Song Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Theranostic Nanomedicine
Twan Lammers et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: Distribution in tumour cells
Shengde Wu et al.
DALTON TRANSACTIONS (2011)
Selective Aggregation of a Platinum-Gadolinium Complex Within a Tumor-Cell Nucleus
Ellen L. Crossley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
A Potent Trans-Diimine Platinum Anticancer Complex Photoactivated by Visible Light
Nicola J. Farrer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Visible Drug Delivery by Supramolecular Nanocarriers Directing to Single-Platformed Diagnosis and Therapy of Pancreatic Tumor Model
Sachiko Kaida et al.
CANCER RESEARCH (2010)
Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity
Zuqin Xue et al.
CHEMICAL COMMUNICATIONS (2010)
X-ray structure and mechanism of RNA polymerase II stalled at an antineoplastic monofunctional platinum-DNA adduct
Dong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
Darren Griffith et al.
CHEMICAL COMMUNICATIONS (2009)
Synthesis, crystal structures, DNA binding and oxidative cleavage studies of copper(II) complexes of N2S2 tetradentate ligands
Si-Ping Tang et al.
POLYHEDRON (2009)
Imaging in the era of molecular oncology
Ralph Weissleder et al.
NATURE (2008)
cis-diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent:: Uptake, structure, function, and prospects
Katherine S. Lovejoy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Strategies for increasing the sensitivity of gadolinium based MRI contrast agents
Peter Caravan
CHEMICAL SOCIETY REVIEWS (2006)
Studies of interaction of dichloro[η2-dimethyl-(2-methylidene-cyclohexylmethyl)-amino]platinum(II) with DNA:: Effects on secondary and tertiary structures of DNA -: Cytotoxic assays on human cancer cell lines Capan 1 and A431
M Gay et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Solid-phase synthesis, characterization and DNA binding properties of the first chloro(polypyridyl)ruthenium conjugated peptide complex
K Karidi et al.
DALTON TRANSACTIONS (2005)
Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy
ME Oehlsen et al.
INORGANIC CHEMISTRY (2003)
Potential MRI contrast agents based on micellar incorporation of amphiphilic bis(alkylamide) derivatives of [(Gd-DTPA)(H2O)]2-
K Kimpe et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2003)
Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent
H Kobayashi et al.
KIDNEY INTERNATIONAL (2002)